Back
Bio-Path Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
18
BPTH
Bio-Path Holdings
Last Price:
0.83
Seasonality Move:
-1.41%
Sell
33
NBY
NovaBay Pharmaceuticals
Last Price:
0.69
Seasonality Move:
-0.57%
Sell
18
Bio-Path Holdings (BPTH)
is a Sell
Is Bio-Path Holdings a Buy, Sell or Hold?
- The current Bio-Path Holdings [BPTH] share price is $0.81. The Score for BPTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- BPTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPTH Stock Price Chart
What is Bio-Path Holdings's stock price today?
-
The Bio-Path Holdings share price today is $0.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPTH is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.
BPTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 35.21 | Sell |
| Chaikin Money Flow: | -111988 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.9 - 1.1) | Sell |
| Bollinger Bands (100): | (0.9 - 1.64) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 53.49 | Buy |
| Chaikin Money Flow: | -8154 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.6 - 0.74) | Buy |
| Bollinger Bands (100): | (0.27 - 1.57) | Sell |
BPTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.88 | Sell |
| 20-day SMA: | 0.97 | Sell |
| 50-day SMA: | 0.98 | Sell |
| 200-day SMA: | 2.78 | Sell |
| 8-day EMA: | 0.89 | Sell |
| 20-day EMA: | 0.94 | Sell |
| 50-day EMA: | 1.06 | Sell |
| 200-day EMA: | 4.01 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.72 | Sell |
| 20-day SMA: | 0.68 | Buy |
| 50-day SMA: | 0.64 | Buy |
| 200-day SMA: | 2.44 | Sell |
| 8-day EMA: | 0.72 | Sell |
| 20-day EMA: | 0.7 | Buy |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 5.82 | Sell |
Bio-Path Holdings Earnings Growth & BPTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.23 per share, and an increase next year of $1.62 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Bio-Path Holdings Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||